3 years ago

In Vivo Bioluminescent Monitoring of Therapeutic Efficacy and Pharmacodynamic Target Assessment of Antofloxacin against Escherichia coli in a Neutropenic Murine Thigh Infection Model.

Xiao-Ping Liao, Jian Sun, Ya-Hong Liu, Yu-Feng Zhou, Meng-Ting Tao, Yu-Zhang He
Antimicrobial resistance among uropathogens has increased infection-related morbidity and mortality. Antofloxacin is a novel fluoroquinolone with broad-spectrum antibacterial activity against urinary Gram-negative bacilli such as Escherichia coli This study monitored the in vivo efficacy of antofloxacin using bioluminescence imaging and determined pharmacokinetic/pharmacodynamic (PK/PD) targets against E. coli isolates in a neutropenic murine thigh infection model. The PK properties were performed after subcutaneous antofloxacin administration of 2.5, 10, 40 and 160 mg/kg. Following thigh infection, mice were treated with 2-fold-increasing doses of antofloxacin from 2.5 to 80 mg/kg administered every 12 hours. Efficacy was assessed by quantitative bacterial burdens in thigh homogenates and was compared with bioluminescent density. Antofloxacin demonstrated both static and killing endpoints in relation to the initial burden against all study strains. The PK/PD index AUC/MIC correlated well with efficacy (R(2)=0.92), and the dose-response relationship was relatively steep as observed with escalating doses of antofloxacin. The mean free drug AUC/MIC targets necessary to produce a net bacterial stasis, 1-log10 and 2-log10 kill for each isolate were 38.7, 66.1 and 147.0 h, respectively. In vivo bioluminescence imaging showed a rapid decrease in bioluminescent density at free drug AUC/MIC exposures that exceeded the stasis targets. The integration of these PD targets combined with PK studies from humans will be useful in setting optimal dosing regimens for treatment of urinary tract infections due to E. coli.

Publisher URL: http://doi.org/10.1128/AAC.01281-17

DOI: 10.1128/AAC.01281-17

You might also like
Discover & Discuss Important Research

Keeping up-to-date with research can feel impossible, with papers being published faster than you'll ever be able to read them. That's where Researcher comes in: we're simplifying discovery and making important discussions happen. With over 19,000 sources, including peer-reviewed journals, preprints, blogs, universities, podcasts and Live events across 10 research areas, you'll never miss what's important to you. It's like social media, but better. Oh, and we should mention - it's free.

  • Download from Google Play
  • Download from App Store
  • Download from AppInChina

Researcher displays publicly available abstracts and doesn’t host any full article content. If the content is open access, we will direct clicks from the abstracts to the publisher website and display the PDF copy on our platform. Clicks to view the full text will be directed to the publisher website, where only users with subscriptions or access through their institution are able to view the full article.